|
[1] Mandanda GA．Henderson ER，Johnson DA，et al．Orthopedic surgery options for the treatment of primary osteosarooma
[J]．Cancer Centrol，2008，15(1)：13-20．
[2] 黎承军,吴苏稼,施鑫.骨肉瘤新辅助化疗疗效评价方法研究进展
[J].医学研究生学报，2007，20(11)：121l-1213．
[3] Ueda Y, Dockhorn-Dworniczak B, Blasius S, et al. Analysis of mutant P53 protein in osteosarcomas and other malignant and benign lesions of bone
[J]. J Cancer Res Clin Oncol, 1993,119(3):172-178.
[4] Kaghad M，Bonnet H，Yang A，et a1．Monoallelically elpressed gen related to p53 at lq36，a region frequently deteted in neumblastoma and other human cancers
[J]．Cell，1997，90(4)：809-819．
[5] Lunghi P, Costanzo A, Mazzera L,et al. The p53 family protein p73 provides new insights into cancer chemosensitivity and targeting
[J]. Clin Cancer Res,2009 ,15(21):6495-6502.
[6] Kommagani R, Whitlatch A, Leonard MK, Kadakia MP. p73 is essential for vitamin D-mediated osteoblastic differentiation
[J]. Cell Death Differ, 2010, 17(3):398-407.
[7] Lunghi P，Costanzo A, Mazzera L，et a1．The p53 family proteinp73 provides new insights into cancer chemosensitivity and targeting
[J]．Clin Cancer Res，2009，15(21)：6495-6502．
[8] Wang XH, O'Connor D, Brimmell M，et a1．The BAG-1 cochaperone is a negative regulator of p73-dependent transcription
[J]．Br J Cancer, 2009, 100(8): 1347-1357.
[9] Berns A. Cancer: The blind spot of p53
[J]. Nature, 2010, 468(7323):519-520.
[10] Kawahara M，Hori T，Chonabayashi K，et a1．Kpm/Lats2 is linked to chemosensitivity of leukemic cells through the stabilization of p73
[J]．Blood，2008，112(9)：3856-3866．
[11] Foshay KM，Gallicano GI．Small RNAs，big potential：the role of MicroRNAs in stem cell function
[J].Curr Stem Cell Res Ther，2007，2(4)：264-271．
[12] Micklem DR，Lorens JB．RNAi screening for therapeutic targets in human malignancies
[J]．Curr Pharm Biotechnol，2007，8(6)：337-343．
[13] Ying SY，Chang DC，Lin SL．The microRNA(miRNA)：overview of the RNA genes that modulate gene function
[J]．Mol Biotechnol，2008，38(3)：257-268．
|
京ICP备08002354号-3
